Medizinische Universität Graz - Research portal
Navigation/Search
- Researchers
- Institutions
- Projects
- Publications
- Partners
- Sponsors
- Equipment
- Knowhow
- Fields of Research
"Faces" of the day:
Selected Publication:
SHR Neuro Cancer Cardio Lipid Metab Microb
Moser, T; Moser, MJ; Mahnert, A.
The best from both disciplines: integrating human and microbial signatures from whole genome sequencing to advance cancer diagnostics.
mSystems. 2025; e0003924
Doi: 10.1128/msystems.00039-24
Web of Science
PubMed
FullText
FullText_MUG
- Leading authors Med Uni Graz
- Mahnert Alexander
- Moser Tina
- Co-authors Med Uni Graz
- Moser Matthias
- Altmetrics:
- Dimensions Citations:
- Plum Analytics:
- Scite (citation analytics):
- Abstract:
- Liquid biopsies are transforming oncology, enabling earlier diagnosis, dynamic treatment guidance, and personalized precision medicine, yet current approaches focusing mainly on circulating host cell-free DNA (cfDNA) neglect crucial information within co-existing microbial cell-free DNA (mcfDNA). This review argues for the combined potential of simultaneously analyzing host and microbial signals from samples like blood, specifically focusing on circulating tumor DNA (ctDNA) as the key host component. While ctDNA analysis is already used to guide treatment decisions, the detection of mcfDNA-although present in smaller amounts compared to total cfDNA-offers a distinct and complementary opportunity to identify disease-causing microbes and investigate the host-associated microbiome in the context of cancer. Leveraging machine learning strategies is essential to integrate these multi-view data sets and realize their full potential for enhancing liquid biopsy applications, particularly in early cancer detection.